Kyle Haraldsen

Kyle Haraldsen is a seasoned executive with extensive experience in technical operations and project management within the pharmaceutical industry. Currently serving as the Chief Technical Operations Officer at Viridian Therapeutics, Inc., Kyle previously held the position of Chief Technology Officer at Lyndra Therapeutics, where leadership focused on platform R&D for innovative drug development. Additional roles include Principal at KBH Consulting Group, Chief Technical Operations Officer at Saniona, and Vice President of Technical Operations at AMAG Pharmaceuticals, where strategic oversight encompassed product development and commercialization. Expertise extends to manufacturing, supply chain management, and regulatory compliance, backed by a Bachelor of Science in Chemical Engineering from Northeastern University.